difenoxin motofen opioid drug used often combination atropine treat principal metabolite first approved us former west difenoxin crosses blood brain barrier induces euphoria often sold administered atropine reduce potential abuse abusedeterring effects atropine used adulterant reasonably effective reducing combinations potential recreational use combines mechanisms naloxone paracetamol two commonly used abusedeterring agents increasing likelihood overdose resulting harmful andor fatal sequelae paracetamol addition reliably producing unpleasant sideeffects spoil opioid euphoria discourage abusers overdosing following initial experience naloxone deter use single doses difenoxin potentiate another opiate anticholingeric activity single tablet actually likely increase pleasurable effects opioid use manner similar combining one opioids orphenadrine high doses strong cns effects atropine high doses causes typical anticholinergic side effects anxiety dysphoria delirium excessive use overdose causes constipation promote development megacolon well classic symptoms overdose including potentially lethal respiratory use children restricted many countries due cns side effects included anorexia nausea vomiting headache drowsiness confusion insomnia dizziness restlessness euphoria difenoxin high peripheralcentral actions ratio working primarily various opioid receptors although capable producing significant central effects high doses doses within normal therapeutic range generally notably impair cognition proprioception resulting therapeutic activity roughly equatable loperamide imodium increased dosages result prominent central opioid effects anticholingeric effects formulation also contains tropane alkaloid therefore offers limited advantages potent antidiarrheal opioid options ex morphine treating intractable cases diarrhea fail respond normal moderately increased difenoxin doses may fact harmful circumstances formulation used also contains atropine hyoscyamine difenoxin schedule drug us combination atropine lessrestrictive category schedule iv account adulterant practice making opioids easily available including abusedeterring adulterating agent standard practice united states pure difenoxin schedule quota grammes acscn combination difenoxin atropine schedule iv dea acscn schedule iv assigned aggregate annual manufacturing httpsenwikipediaorgwikidifenoxin